The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.

The positive transcription elongation factor b (P-TEFb) (CDK9/cyclin T (CycT)) promotes mRNA transcriptional elongation through phosphorylation of elongation repressors and RNA polymerase II. To understand the regulation of a transcriptional CDK by its cognate cyclin, we have determined the structur...

Full description

Bibliographic Details
Main Authors: Baumli, S, Lolli, G, Lowe, E, Troiani, S, Rusconi, L, Bullock, A, Debreczeni, J, Knapp, S, Johnson, L
Format: Journal article
Language:English
Published: 2008
Subjects:
_version_ 1797064888389992448
author Baumli, S
Lolli, G
Lowe, E
Troiani, S
Rusconi, L
Bullock, A
Debreczeni, J
Knapp, S
Johnson, L
author_facet Baumli, S
Lolli, G
Lowe, E
Troiani, S
Rusconi, L
Bullock, A
Debreczeni, J
Knapp, S
Johnson, L
author_sort Baumli, S
collection OXFORD
description The positive transcription elongation factor b (P-TEFb) (CDK9/cyclin T (CycT)) promotes mRNA transcriptional elongation through phosphorylation of elongation repressors and RNA polymerase II. To understand the regulation of a transcriptional CDK by its cognate cyclin, we have determined the structures of the CDK9/CycT1 and free cyclin T2. There are distinct differences between CDK9/CycT1 and the cell cycle CDK CDK2/CycA manifested by a relative rotation of 26 degrees of CycT1 with respect to the CDK, showing for the first time plasticity in CDK cyclin interactions. The CDK9/CycT1 interface is relatively sparse but retains some core CDK-cyclin interactions. The CycT1 C-terminal helix shows flexibility that may be important for the interaction of this region with HIV TAT and HEXIM. Flavopiridol, an anticancer drug in phase II clinical trials, binds to the ATP site of CDK9 inducing unanticipated structural changes that bury the inhibitor. CDK9 activity and recognition of regulatory proteins are governed by autophosphorylation. We show that CDK9/CycT1 autophosphorylates on Thr186 in the activation segment and three C-terminal phosphorylation sites. Autophosphorylation on all sites occurs in cis.
first_indexed 2024-03-06T21:20:45Z
format Journal article
id oxford-uuid:415d9bc8-f4d9-4b77-b42e-7755e9d2ce4a
institution University of Oxford
language English
last_indexed 2024-03-06T21:20:45Z
publishDate 2008
record_format dspace
spelling oxford-uuid:415d9bc8-f4d9-4b77-b42e-7755e9d2ce4a2022-03-26T14:43:16ZThe structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:415d9bc8-f4d9-4b77-b42e-7755e9d2ce4aAmino Acid SequenceBinding SitesFlavonoidsPhosphorylationchemistrySequence AlignmentModels, MolecularCyclin-Dependent Kinase 9CyclinsPiperidinesmetabolismCyclin TMolecular Sequence DataEnglishStructural Genomics Consortium2008Baumli, SLolli, GLowe, ETroiani, SRusconi, LBullock, ADebreczeni, JKnapp, SJohnson, LThe positive transcription elongation factor b (P-TEFb) (CDK9/cyclin T (CycT)) promotes mRNA transcriptional elongation through phosphorylation of elongation repressors and RNA polymerase II. To understand the regulation of a transcriptional CDK by its cognate cyclin, we have determined the structures of the CDK9/CycT1 and free cyclin T2. There are distinct differences between CDK9/CycT1 and the cell cycle CDK CDK2/CycA manifested by a relative rotation of 26 degrees of CycT1 with respect to the CDK, showing for the first time plasticity in CDK cyclin interactions. The CDK9/CycT1 interface is relatively sparse but retains some core CDK-cyclin interactions. The CycT1 C-terminal helix shows flexibility that may be important for the interaction of this region with HIV TAT and HEXIM. Flavopiridol, an anticancer drug in phase II clinical trials, binds to the ATP site of CDK9 inducing unanticipated structural changes that bury the inhibitor. CDK9 activity and recognition of regulatory proteins are governed by autophosphorylation. We show that CDK9/CycT1 autophosphorylates on Thr186 in the activation segment and three C-terminal phosphorylation sites. Autophosphorylation on all sites occurs in cis.
spellingShingle Amino Acid Sequence
Binding Sites
Flavonoids
Phosphorylation
chemistry
Sequence Alignment
Models, Molecular
Cyclin-Dependent Kinase 9
Cyclins
Piperidines
metabolism
Cyclin T
Molecular Sequence Data
Baumli, S
Lolli, G
Lowe, E
Troiani, S
Rusconi, L
Bullock, A
Debreczeni, J
Knapp, S
Johnson, L
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
title The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
title_full The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
title_fullStr The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
title_full_unstemmed The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
title_short The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
title_sort structure of p tefb cdk9 cyclin t1 its complex with flavopiridol and regulation by phosphorylation
topic Amino Acid Sequence
Binding Sites
Flavonoids
Phosphorylation
chemistry
Sequence Alignment
Models, Molecular
Cyclin-Dependent Kinase 9
Cyclins
Piperidines
metabolism
Cyclin T
Molecular Sequence Data
work_keys_str_mv AT baumlis thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT lollig thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT lowee thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT troianis thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT rusconil thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT bullocka thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT debreczenij thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT knapps thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT johnsonl thestructureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT baumlis structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT lollig structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT lowee structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT troianis structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT rusconil structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT bullocka structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT debreczenij structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT knapps structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation
AT johnsonl structureofptefbcdk9cyclint1itscomplexwithflavopiridolandregulationbyphosphorylation